24 May 2013
Keywords: eirx, ups, its, stake, auvation, ireland-based, therapeutics
Article | 23 May 2005
Ireland-based EiRx Therapeutics has increased its stake in Scotland's cancer therapy firm Auvation to 95%, from the 75.1% to which it upped
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 May 2005
23 May 2013
© 2013 thepharmaletter.com